Drugs / Centella asiatica
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05591027 | Dec 2022 → Nov 2025 overdue | Alzheimer disease, cognitive impairment with or without cerebellar ataxia | Oregon Health and Science University | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01414374 | Jan → Dec 2012 | iron deficiency anemia | Casa Espirita Terra de Ismael | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07697209 | Mar → Sep 2025 | periodontitis | Mansoura University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT04886882 Comparator | Mar → Jun 2021 | — | Başakşehir Çam & Sakura City Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03815305 Comparator | Jul 2018 → Jan 2019 | type 2 diabetes mellitus | Indonesia University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Centella asiatica | “Centella asiatica tincture, 40 drops, BID” NCT01414374 ↗ |
| Known as | C. asiatica | “Group I (study group): 15 Patients with periodontitis Stage III will be treated with C. asiatica nanoemulsion as an adjunct to SRP.” NCT07697209 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica)” NCT01414374 ↗ |
| Route | Topical | “1% centella asiatica ointment” NCT03815305 ↗ |